Viewing Study NCT00807092


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2026-07-02 @ 11:30 AM
Study NCT ID: NCT00807092
Status: COMPLETED
Last Update Posted: 2015-03-04
First Post: 2008-12-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 2 View
Keywords: